Pacific Biosciences Of California Shares Outstanding 2009-2018 | PACB

Current and historical number of shares outstanding for Pacific Biosciences Of California (PACB) from 2009 to 2018. Diluted shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options.
Pacific Biosciences Of California Annual Shares Outstanding
(Millions of US $)
2017 $106
2016 $89
2015 $76
2014 $70
2013 $63
2012 $56
2011 $54
2010 $10
2009 $1
2008 $0
2007 $0
Pacific Biosciences Of California Quarterly Shares Outstanding
(Millions of US $)
Q2 2018 $132
Q1 2018 $124
Q4 2017 $106
Q3 2017 $116
Q2 2017 $97
Q1 2017 $93
Q4 2016 $89
Q3 2016 $92
Q2 2016 $88
Q1 2016 $84
Q4 2015 $76
Q3 2015 $80
Q2 2015 $75
Q1 2015 $74
Q4 2014 $70
Q3 2014 $71
Q2 2014 $71
Q1 2014 $68
Q4 2013 $63
Q3 2013 $66
Q2 2013 $62
Q1 2013 $57
Q4 2012 $56
Q3 2012 $56
Q2 2012 $56
Q1 2012 $55
Q4 2011 $54
Q3 2011 $54
Q2 2011 $53
Q1 2011 $53
Q4 2010 $10
Q3 2010 $1
Q2 2010 $1
Q1 2010 $1
Q4 2009 $0
Q3 2009 $1
Q4 2008 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.581B $0.093B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $93.215B 22.36
Intuitive Surgical (ISRG) United States $59.265B 56.57
Fresenius Medical Care (FMS) Germany $29.358B 20.74
Edwards Lifesciences (EW) United States $28.908B 32.56
IDEXX Laboratories (IDXX) United States $21.087B 64.08
ABIOMED (ABMD) United States $16.956B 138.91
Hologic (HOLX) United States $11.065B 18.82
DexCom (DXCM) United States $10.899B 0.00
Teleflex (TFX) United States $10.447B 24.85
Varian Medical Systems (VAR) United States $10.178B 25.62
STERIS (STE) United Kingdom $9.709B 26.70
LivaNova (LIVN) United Kingdom $5.976B 35.65
Masimo (MASI) United States $5.677B 37.80
Integra LifeSciences Holdings (IART) United States $5.353B 27.70
Globus Medical (GMED) United States $5.144B 34.22
Inogen (INGN) United States $4.848B 128.30
Penumbra (PEN) United States $4.275B 388.59
Cantel Medical (CMD) United States $3.989B 41.58
Opko Health (OPK) United States $3.034B 0.00
Wright Medical Group (WMGI) Netherlands $2.990B 0.00
Halyard Health (AVNS) United States $2.966B 24.41
Integer Holdings (ITGR) United States $2.263B 20.49
Nevro (NVRO) United States $1.934B 0.00
Tandem Diabetes Care (TNDM) United States $1.644B 0.00
AxoGen (AXGN) United States $1.474B 0.00
Glaukos (GKOS) United States $1.464B 839.00
Mazor Robotics (MZOR) Israel $1.309B 0.00
Luminex (LMNX) United States $1.213B 35.79
CryoLife (CRY) United States $1.208B 105.97
Accelerate Diagnostics (AXDX) United States $1.204B 0.00
Natus Medical (BABY) United States $1.187B 25.18
Tactile Systems Technology (TCMD) United States $1.048B 178.59
K2Ms (KTWO) United States $0.909B 0.00
Intersect ENT (XENT) United States $0.838B 0.00
AngioDynamics (ANGO) United States $0.788B 29.25
Mesa Laboratories (MLAB) United States $0.782B 48.40
ViewRay (VRAY) United States $0.744B 0.00
Sientra (SIEN) United States $0.594B 0.00
Neuronetics (STIM) United States $0.561B 0.00
Quotient (QTNT) Switzerland $0.417B 0.00
Veracyte (VCYT) United States $0.414B 0.00
GenMark Diagnostics (GNMK) United States $0.411B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.376B 0.00
OrthoPediatrics (KIDS) United States $0.353B 0.00
Accuray (ARAY) United States $0.330B 0.00
IRadimed (IRMD) United States $0.296B 106.54
RTI Surgical (RTIX) United States $0.285B 56.25
T2 Biosystems (TTOO) United States $0.283B 0.00
Fluidigm (FLDM) United States $0.281B 0.00
Nuvectra (NVTR) United States $0.259B 0.00
Pulse Biosciences (PLSE) United States $0.254B 0.00
Helius Medical Technologies (HSDT) United States $0.213B 0.00
SeaSpine Holdings (SPNE) United States $0.205B 0.00
Apollo Endosurgery (APEN) United States $0.170B 0.00
Ekso Bionics Holdings (EKSO) United States $0.160B 0.00
Alphatec Holdings (ATEC) United States $0.137B 0.00
Second Sight Medical Products (EYES) United States $0.108B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.097B 0.00
EDAP TMS (EDAP) France $0.091B 0.00
Invuity (IVTY) United States $0.087B 0.00
Viveve Medical (VIVE) United States $0.082B 0.00
Neovasc (NVCN) Canada $0.067B 0.00
ConforMIS (CFMS) United States $0.061B 0.00
Restoration Robotics (HAIR) United States $0.043B 0.00
Vermillion (VRML) United States $0.041B 0.00
Presbia (LENS) Ireland $0.037B 0.00
Lianluo Smart (LLIT) China $0.033B 0.00
OBALON THERPTCS (OBLN) United States $0.031B 0.00
ReWalk Robotics (RWLK) Israel $0.029B 0.00
Titan Medical (TMDI) Canada $0.028B 0.00
Microbot Medical (MBOT) United States $0.027B 0.00
DarioHealth (DRIO) Israel $0.026B 0.00
PAVmed (PAVM) United States $0.025B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
Nanovibronix (NAOV) United States $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
ENDRA Life Sciences (NDRA) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.006B 0.00
Amedica (AMDA) United States $0.002B 0.00
EnteroMedics (RSLS) United States $0.001B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00